Author/Authors :
Dehghani, Alireza Department of Ophthalmology - Isfahan Eye Research Center - Isfahan University of Medical Sciences, Isfahan, Iran , Alemzadeh‐Ansari, Mohammad‐Hasan Department of Ophthalmology - Isfahan Eye Research Center - Isfahan University of Medical Sciences, Isfahan, Iran , Masjedi, Marjan Department of Ophthalmology - Isfahan Eye Research Center - Isfahan University of Medical Sciences, Isfahan, Iran , Amirkhani, Arman Department of Ophthalmology - Isfahan Eye Research Center - Isfahan University of Medical Sciences, Isfahan, Iran , Pourazizi, Mohsen Department of Ophthalmology - Isfahan Eye Research Center - Isfahan University of Medical Sciences, Isfahan, Iran
Abstract :
Erectile dysfunction (ED) has negative effects on quality of life. The first line of
oral medication for this condition is phosphodiesterase type 5 inhibitors (PDE5I)
including Tadalafil. Ocular complications associated with Tadalafil are rare
and usually occurred in participant with known risk factors. In this report, we
describe and review the related literature of development of nonarteritic anterior
ischemic optic neuropathy ‐associated Tadalafil. A healthy nonsmoking 42‐year‐old
male with a history of ED presented with acute onset of an inferior visual field
defect on the right eye. Automated perimetry showed inferior altitudinal loss in
the affected eye. The administration of Tadalafil was discontinued as a potential
causative agent for this condition. During follow‐up, neither improvement signs
nor symptoms revealed.
